Search results for "Italy"

showing 10 items of 2893 documents

A museum system of design/craft for sustainable development in southern Italy

2018

Abstract: In this extended abstract we are going to explain an academic project entitled “THE SYSTEM OF TERRITORIAL DESIGN SYSTEMS. Cultural tourism, craftsmanship and design for the local development of the production enterprises of excellence in Southern Italy and Made in Italy”. It is based on the cooperation among designers and artisans in order to encourage the development of local craft- based production, by creating a REGIONAL MUSEUM SYSTEM OF DESIGN AND APPLIED ARTS in the five regions of Southern Italy. Then, the “SYSTEM OF THE SYSTEMS” is constituted of the five specific museum systems to be created in each region; these systems - especially in Campania and Sicily – can then repre…

Social sustainabilityMuseum systems.Handmade in ItalyCraftArtidesignSettore ICAR/13 - Disegno Industriale
researchProduct

The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies

2021

The term liquid biopsy (LB) refers to the use of various biological fluids as a surrogate for neoplastic tissue to achieve information for diagnostic, prognostic and predictive purposes. In the current clinical practice, LB is used for the identification of driver mutations in circulating tumor DNA derived from both tumor tissue and circulating neoplastic cells. As suggested by a growing body of evidence, however, there are several clinical settings where biological samples other than tissue could be used in the routine practice to identify potentially predictive biomarkers of either response or resistance to targeted treatments. New applications are emerging as useful clinical tools, and o…

Societies ScientificCancer ResearchContext (language use)ReviewNeoplastic CellsBioinformaticsCirculating tumor cellCirculatingBiomarkers TumorMedicineHumansDigital polymerase chain reactionLiquid biopsycfDNAcirculating tumor DNAcfDNA; circulating cell-free DNA; circulating tumor DNA; ctDNA; digital PCR; liquid biopsy; next-generation sequencing; real-time PCRTumorCirculating Neoplastic Cellsliquid biopsybusiness.industrydigital PCRScientificctDNAcirculating cell-free DNANeoplastic Cells CirculatingCirculating Cell-Free DNAcfDNA; circulating cell-free DNA; circulating tumor DNA; ctDNA; digital PCR; liquid biopsy; next-generation sequencing; real-time PCR; Biomarkers Tumor; Humans; Italy; Liquid Biopsy; Neoplastic Cells Circulating; Societies ScientificOncologyItalyCirculating tumor DNAPosition papernext-generation sequencingSocietiesbusinessreal-time PCRBiomarkersHuman
researchProduct

The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societi…

2021

The personalized medicine is in a rapidly evolving scenario. The identification of actionable mutations is revolutionizing the therapeutic landscape of tumors. The morphological and histological tumor features are enriched by the extensive genomic profiling, and the first tumor-agnostic drugs have been approved regardless of tumor histology, guided by predictive and druggable genetic alterations. This new paradigm of "mutational oncology", presents a great potential to change the oncologic therapeutic scenario, but also some critical aspects need to be underlined. A process governance is mandatory to ensure the genomic testing accuracy and homogeneity, the economic sustainability, and the r…

Societies ScientificGenomic profilingDruggabilityNTRK-FusionsMedical OncologyNeoplasmsMedicineHumansAgnostic biomarkersPrecision MedicineHistology-agnosticTumor histologybusiness.industryAgnostic biomarkers; Agnostic drugs; Histology-agnostic; Homologous recombination deficiency; Microsatellite instability; Mismatch repair deficiency; NTRK-Fusions; Precision oncology; Humans; Italy; Medical Oncology; Precision Medicine; Neoplasms; Societies ScientificScientificPrecision oncologyHematologyPrecision medicineData scienceAgnostic drugsOncologyEconomic sustainabilityItalyAgnostic biomarkerMicrosatellite instabilityPosition paperNeoplasmIdentification (biology)Personalized medicineAgnostic drugNTRK-FusionbusinessSocietiesHomologous recombination deficiencyMismatch repair deficiencyHuman
researchProduct

Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Itali…

2022

Constitutional BRCA1/BRCA2 pathogenic or likely pathogenic variants (PVs) are associated with an increased risk for developing breast and ovarian cancers. Current evidence indicates that BRCA1/2 PVs are also associated with pancreatic cancer, and that BRCA2 PVs are associated with prostate cancer risk. The identification of carriers of constitutional PVs in the BRCA1/2 genes allows the implementation of individual and family prevention pathways, through validated screening programs and risk-reducing strategies. According to the relevant and increasing therapeutic predictive implications, the inclusion of BRCA testing in the routine management of patients with breast, ovarian, pancreatic and…

Societies ScientificMaleOvarian NeoplasmsCancer Researchgenetic counselingBRCABRCA testing; BRCA-related cancer; BRCA1; BRCA2; PARP inhibitors; genetic counseling; pancreatic ductal adenocarcinomaProstatic Neoplasmspancreatic ductal adenocarcinomaScientificSettore MED/03 - GENETICA MEDICABRCA testing; BRCA-related cancer; BRCA1; BRCA2; PARP inhibitors; genetic counseling; pancreatic ductal adenocarcinoma; Female; Humans; Italy; Male; Societies Scientific; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic NeoplasmsBRCA1BRCA2BRCA-related cancerPancreatic NeoplasmsBRCA testingPARP inhibitorOncologyItalyHumansFemaleSocietiesPARP inhibitors
researchProduct

The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-S…

2022

The development of innovative technologies and the advances in the genetics and genomics, have offered new opportunities for personalized treatment in oncology. Although the selection of the patient based on the molecular characteristics of the neoplasm has the potential to revolutionize the therapeutic scenario of oncology, this approach is extremely challenging. The access, homogeneity, and economic sustainability of the required genomic tests should be warranted in the clinical practice, as well as the specific scientific and clinical expertise for the choice of medical therapies. All these elements make essential the collaboration of different specialists within the Molecular Tumor Boar…

Societies ScientificMolecularScientificPrecision oncologyHematologyGenomicsMolecular profiling; Molecular tumor board; Mutational oncology; Precision oncologyMolecular tumor boardSettore MED/03 - GENETICA MEDICAMedical OncologyMolecular profilingMutational oncologyOncologyItalyNeoplasmsMolecular profiling; Molecular tumor board; Mutational oncology; Precision oncology; Genomics; Humans; Italy; Medical Oncology; Neoplasms; Societies ScientificGenomicNeoplasmHumansSocietiesHuman
researchProduct

Position paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL

2018

Although direct oral anticoagulants (DOAC) do not require dose-adjustment on the basis of laboratory test results, the measurement of their anticoagulant effect is useful in special situations. This position paper issued by the Italian Scientific Societies that are mainly involved in the management of patients on DOAC is aimed at providing guidance to care-givers on which tests should be used and the situations in which testing is useful. The guidance is based on the data from the literature so far available and/or on consensus among experts.

Societies ScientificOralConsensusDOACAnticoagulantAnticoagulation; Consensus; DOAC; Thrombosis; Administration Oral; Anticoagulants; Drug Monitoring; Humans; Italy; Societies Scientific; Immunology and Allergy; HematologyAdministration OralAnticoagulantsConsensuThrombosisScientificHematologyLong-Term CareAnticoagulationSettore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicaItalyThrombosiAdministrationHumansImmunology and AllergyPosition PaperDOAC; anticoagulation; thrombosis; consensusDrug MonitoringSocietiesHuman
researchProduct

Prevalenza di sovrappeso e obesità in Italia: questione meridionale o disagio sociale?

2016

Overweight and obesity represent a topic of growing interest for most of the national healthcare plans of developed countries, mainly due to the increasing prevalence of overweight and obesity, and to their presence as a risk factor for many other noncommunicable diseases. The present work aims at providing a profile of overweight and obesity in Italy, and to analyze the impact of different territorial and socioeconomic risk factors. Data derived from Istat survey on “Health conditions and healthcare utilization” 2005 and 2013 are used, and Prevalence Risk Ratio estimates are derived through modified Poisson regression models. The results show higher prevalence of overweight and obesity in …

Socioeconomic factorItalyObesitySettore SECS-S/05 - Statistica SocialeOverweightLife Style
researchProduct

A Universal Health Care System? Unmet Need for Medical Care Among Regular and Irregular Immigrants in Italy

2017

Italy has a universal health care system that covers, in principle, the whole resident population, irrespective of citizenship and legal status. This study calculates the prevalence of unmet need for medical care among Italian citizens, regular and irregular immigrants and estimates logistic regression models to assess whether differences by citizenship and legal status hold true once adjusting for potential confounders. The analysis is based on two Surveys on Income and Living Conditions of Italian households and households with foreigners. Controlling for various factors, the odds of experiencing unmet need for medical care are 27% higher for regular immigrants than for Italian citizens a…

SociologiEpidemiologyHealth StatusImmigration Legal status&nbspVulnerabilityUnmet need  Health care access  Immigrants  Legal status  Italy Health Services AccessibilityState MedicineUnmet need&nbsp0302 clinical medicineSociologyHealth care030212 general & internal medicineSociologyCitizenshiphealth care economics and organizationsmedia_commoneducation.field_of_studyUndocumented ImmigrantsAge FactorsPublic Health Global Health Social Medicine and EpidemiologyItalyLegal status0305 other medical scienceUnmet needmedicine.medical_specialtymedia_common.quotation_subject Immigrants&nbspPopulationEmigrants and Immigrants Italy&nbspHV Social pathology. Social and public welfare. CriminologyOdds03 medical and health sciencesSex FactorsImmigrantsmedicineHumanseducationPovertyDG Italy030505 public healthPovertybusiness.industryPublic healthPublic Health Environmental and Occupational HealthSettore SECS-S/04 - DemografiaHealth care access&nbspJV Colonies and colonization. Emigration and immigration. International migrationFolkhälsovetenskap global hälsa socialmedicin och epidemiologiSocioeconomic FactorsChronic DiseaseRA Public aspects of medicineHealth care accessSocial CapitalbusinessDemography
researchProduct

Diversification of diversity: Migrations, cultural pluralism and urban transformations in Palermo (Italy): a case study

2021

Italy experienced the transition from a country of emigration to a country of immigration only in the last decade of the 20th century. The extreme heterogeneity of the Italian scene – from the distribution and variety of productive sectors and local economic dimensions, to the geographical, cultural and linguistic varieties – results in an incredibly differentiated background on which the phenomenon of migrations fits as multiplier of diversity. But there are some particular fields in Italy where the challenges of superdiversity appear to be more prominent: the impact on the school system, in terms of linguistic-cultural pluralism; the change in religious belonging and identities; the dynam…

Sociology and Political Scienceschoolmedia_common.quotation_subject05 social sciencesImmigration0211 other engineering and technologies0507 social and economic geographyurban space021107 urban & regional planning02 engineering and technologyDiversification (marketing strategy)migrationsuperdiversityEmigrationItalySettore SPS/11 - Sociologia Dei Fenomeni PoliticiCulture and religionSettore SPS/07 - Sociologia GeneraleSociologyEconomic geography050703 geographyCultural pluralismDiversity (politics)media_commonCurrent Sociology
researchProduct

Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy

2021

Background: Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. Aim: To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Methods: Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infection were tested for HCV RNA, HCV genotyping, and NS3, NS5A, and NS5B HCV genomic region sequencing. To identify transmission clusters, phylogenetic trees were built for each…

SofosbuvirClinical risk management Hepatitis C virus (HCV) Molecular epidemiology Nosocomial outbreak Phylogenetic analysis Antiviral Agents Bayes Theorem Disease Outbreaks Genotype Hepacivirus Humans Italy Phylogeny Risk Management Hepatitis C ThalassemiaHepacivirusHepacivirus030501 epidemiologySettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeDisease OutbreaksSettore MED/07chemistry.chemical_compoundSettore BIO/13 - Biologia ApplicataEpidemiologyMedicinePhylogenySettore MED/12 - Gastroenterologia0303 health sciencesClinical risk managementPhylogenetic analysisbiologyTransmission (medicine)virus diseasesGeneral MedicineHepatitis CHepatitis C virus (HCV)Hepatitis CInfectious DiseasesItalyMolecular epidemiologyThalassemia0305 other medical sciencemedicine.drugMicrobiology (medical)Ledipasvirmedicine.medical_specialtyGenotypeHepatitis C virusAntiviral Agents03 medical and health sciencesPhylogenetic analysiInternal medicineHumansRisk Management030306 microbiologybusiness.industryNosocomial outbreakBayes Theorembiology.organism_classificationmedicine.diseasedigestive system diseasesChronic infectionchemistrybusiness
researchProduct